Comparative economic evaluation of dutasteride versus finasteride for Medicare-aged men with benign prostatic hyperplasia

被引：0
|
作者：
Lin, P. J.
Shah, M.
Davis, E. A.
Hogue, S. L.
机构：
[1] GlaxoSmithKline Inc, Res Triangle Pk, NC USA
[2] Univ N Carolina, GSK, Chapel Hill, NC USA
[3] Xcenda, Palm Harbor, FL USA
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70961-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A305 / A305
页数：1
相关论文
共 50 条
  • [21] Re: Rates of Prostate Surgery and Acute Urinary Retention for Benign Prostatic Hyperplasia in Men Treated with Dutasteride or Finasteride Editorial Comment
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2017, 198 (04): : 719 - 719
  • [22] Finasteride versus dutasteride: A real-world economic evaluation
    Fenter, Thomas C.
    Runken, M. Chris
    Black, Libby
    Eaddy, Michael
    AMERICAN JOURNAL OF MANAGED CARE, 2007, 13 (01): : S23 - S27
  • [23] Re: Comparing Clinical and Economic Outcomes Associated with Early Initiation of Combination Therapy of an Alpha Blocker and Dutasteride or Finasteride in Men with Benign Prostatic Hyperplasia in the United States
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2018, 199 (04): : 868 - 869
  • [24] Effect of dutasteride on the incidence of prostate cancer (PCA) in men with benign prostatic hyperplasia
    Andriole, GL
    Roehrborn, CG
    Schulman, C
    Slawin, KM
    Somerville, M
    Rittmaster, RS
    JOURNAL OF UROLOGY, 2004, 171 (04): : 117 - 117
  • [25] EFFECT OF DUTASTERIDE ON INTRAPROSTATIC LEVELS OF ESTROGENS AND ANDROGENS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
    Takizawa, Itsuhiro
    Ishizaki, Fumio
    Miyashiro, Yoshimichi
    Komeyama, Takeshi
    Morishita, Hideo
    Nishiyama, Tsutomu
    JOURNAL OF UROLOGY, 2015, 193 (04): : E358 - E358
  • [26] Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia - Reply
    Andriole, GL
    UROLOGY, 2004, 64 (03) : 543 - 543
  • [27] Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
    Antonino Catalano
    Gabriella Martino
    Federica Bellone
    Maria Papalia
    Carmen Lasco
    Giorgio Basile
    Alberto Sardella
    Giacomo Nicocia
    Nunziata Morabito
    Antonino Lasco
    Clinical Drug Investigation, 2019, 39 : 103 - 103
  • [28] Effect of dutasteride on reduction of plasma DHT following finasteride therapy in patients with benign prostatic hyperplasia.
    Botto, H
    Lan, O
    Poulain, JE
    Comenducci, A
    PROGRES EN UROLOGIE, 2005, 15 (06): : 1090 - 1095
  • [29] Finasteride or dutasteride for the pharmacological treatment for male lower urinary tract symptoms due to benign prostatic hyperplasia?
    Alcantara-Montero, A.
    Brenes-Bermudez, F. J.
    ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (04): : 268 - 269
  • [30] Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)
    Nickel, J. Curtis
    Gilling, Peter
    Tammela, Teuvo L.
    Morrill, Betsy
    Wilson, Timothy H.
    Rittmaster, Roger S.
    BJU INTERNATIONAL, 2011, 108 (03) : 388 - 394
12345